Cite
A novel variant of transthyretin (Glu42Asp) associated with sporadic late-onset cardiac amyloidosis.
MLA
Dupuy, O., et al. “A Novel Variant of Transthyretin (Glu42Asp) Associated with Sporadic Late-Onset Cardiac Amyloidosis.” Amyloid : The International Journal of Experimental and Clinical Investigation : The Official Journal of the International Society of Amyloidosis, vol. 5, no. 4, Dec. 1998, pp. 285–87. EBSCOhost, https://doi.org/10.3109/13506129809007302.
APA
Dupuy, O., Blétry, O., Blanc, A. S., Droz, D., Viémont, M., Delpech, M., & Grateau, G. (1998). A novel variant of transthyretin (Glu42Asp) associated with sporadic late-onset cardiac amyloidosis. Amyloid : The International Journal of Experimental and Clinical Investigation : The Official Journal of the International Society of Amyloidosis, 5(4), 285–287. https://doi.org/10.3109/13506129809007302
Chicago
Dupuy, O, O Blétry, A S Blanc, D Droz, M Viémont, M Delpech, and G Grateau. 1998. “A Novel Variant of Transthyretin (Glu42Asp) Associated with Sporadic Late-Onset Cardiac Amyloidosis.” Amyloid : The International Journal of Experimental and Clinical Investigation : The Official Journal of the International Society of Amyloidosis 5 (4): 285–87. doi:10.3109/13506129809007302.